4D Lifetec
Pioneering company in non-genomic liquid biopsy cancer diagnostic
4D Lifetec has raised €1.9M across 1 funding round, most recently a Series B round in Jul 2022. Based in Zug, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.9M
€1,917,062
Funding rounds
1
Investors
0
distinct backers
Active since
2022-07
latest 2022-07
Funding by year
EUR raised per year4D Lifetec — funding by year — interactive chart.
Data table
| 4D Lifetec — funding by year | |
|---|---|
| 2022 | €1.9M |
Signals
Medium confidenceRaise-next likelihood10
base rate 48% for Series B
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-18 | Series B | €1.9M | — | View deal → |
Related news
- 4D Lifetec banks CHF 1.9 in series B roundstartupticker.ch · 2022-07
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData